Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jul 16;46(7):7548-7557.
doi: 10.3390/cimb46070448.

Phytotherapy-Induced Hepatocytotoxicity: A Case Report

Affiliations
Case Reports

Phytotherapy-Induced Hepatocytotoxicity: A Case Report

Stephen Malnick et al. Curr Issues Mol Biol. .

Abstract

Herbal and complementary medicine are frequently integrated with conventional medicine. We aim to report a case of severe herbal-induced liver injury (HILI) due to chronic use of green tea and protein shake. We present both clinical and laboratory evidence implicating mitochondrial toxicity and an immune response leading to a hypersensitivity reaction to the products. We have recently treated a 39-year-old man with hepatotoxicity resulting from a combination of a green tea-containing powder and a branched-chain amino acid supplement that was commenced 2 months previously. The hepatotoxicity resolved by stopping the consumption of these products and no other cause was detected. We decided to perform a lymphocyte toxicity assay (LTA) to determine if there was laboratory support for this diagnosis. LTA (% toxicity) represents the response of the mitochondria to toxic injury. To determine the role of the proinflammatory and anti-inflammatory cytokines and chemokines in the patient's reaction, we measured the level of cytokines and chemokine in the media of growing cells, exposed to each product or to a combination of products. The increased cytokines and chemokines are presented as the x-fold elevations from the upper limit of normal (ULN) for matrix metalloproteinase (MMP) (pg/mL × 1.5 ULN) and interleukin (IL)-1β (pg/mL × 1.8 ULN). Higher elevations were found for interferon (IFN)-β, IFN-γ, IL-8, IL 13, IL-15 (pg/mL × 2 ULN), regulated upon activation, normal T cell expressed and presumably secreted (RANTES) (pg/mL × 2 ULN), and nuclear factor (NFκB) (pg/mL × 3 ULN). The highest increases were for vascular endothelial factor (VEGF) (pg/mL × 10 ULN), tumor necrosis factor (TNF)-α, and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) (pg/mL × 13 ULN). An examination of cellular markers showed the difference between programmed cell death (apoptosis) and cell death due to necrosis. In our case, cytokeratin-ccK18 (M-30) U/L was within the normal limits, suggesting that apoptosis was normal, while ccK8(M65) U/L was elevated at 1.5 × ULN. This result implies that upon the treatment of the patient's lymphocytes with the products, the mechanism of toxicity is necrosis. In susceptible individuals, the combination of protein and herbal tea produces mitochondrial toxicity and a strong T-lymphocyte-1 response, leading to HILI. There is a need of international reporting of adverse drug reactions by clinicians, laboratories, and pharmaceutical manufacturers to drug regulatory authorities. This requires internationally accepted standard definitions of reactions, as well as criteria for assessment.

Keywords: apoptosis; caspase; drug-induced liver injury; herbal-induced liver injury; lymphocyte toxicity assay; necrosis; proinflammatory cytokines.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. All the authors contributed actively to the review. All authors disclose that they have no actual or potential conflicts of interest, including any financial, personal, or other relationships with other people or organizations that could inappropriately influence or be perceived to influence their work.

Figures

Figure 1
Figure 1
LTA (% toxicity).

References

    1. Zimmerman H.J. The spectrum of hepatotoxicity. Perspect. Biol. Med. 1968;12:135–161. doi: 10.1353/pbm.1968.0004. - DOI - PubMed
    1. Navarro V.J., Senior J.R. Drug-related hepatotoxicity. N. Engl. J. Med. 2006;354:731–739. doi: 10.1056/NEJMra052270. - DOI - PubMed
    1. Zimmerman H.J. Hepatotoxicity: The Adverse Effects of Drug and Other Chemicals on the Hepatic. Lippinocott, Williams and Wilkins; Philadelphia, PA, USA: 1999.
    1. Lee W.M., Senior J.R. Recognizing drug-induced liver injury: Current problems, possible solutions. Toxicol. Pathol. 2005;33:155–164. doi: 10.1080/01926230590522356. - DOI - PubMed
    1. Malnick S., Maor Y., Melzer E., Ziv-Sokolowskaia N.N., Neuman M.G. Severe hepatocytotoxicity linked to denosumab. Eur. Rev. Med. Pharmacol. Sci. 2017;21:78–85. - PubMed

Publication types

LinkOut - more resources